Stocks Moving From Alpha-Rich Ideas
The Toronto-listed shares of Maple Leaf Foods [(MLFNF)(MFI.TO)] are +20.5% since Oct. 2, when Mike Arnold noted the company's restructuring carries up to 50% upside over the next two years. Read article »
Adecoagro (AGRO) is +31% since July, when Stephen Simpson said the pessimism surrounding the shares ignores continued opportunities in Brazilian ethanol. Read article »
Breaking Alpha-Rich Ideas (for Pro Subscribers) Learn more »
The Biodiesel Tide Is Going Out: Neste Oil Is Swimming Naked, 75% Downside by Asset Plays Investing
Societe D'Edition Canal Plus: A Low-Risk Bet On Further Vivendi Restructuring by Mike Arnold
ModusLink: An Operational Turnaround, A Big Hidden Asset, An Activist, And A Low Valuation by Weighing Machine
Southern Missouri Bancorp: An Upward Reversion To The Mean by Intangible Valuation
Long Ideas
General Electric: Substantial Upside From Multiple Expansion by Josh Arnold
Sirius XM: In Serious Trouble? Not Really by Leah Frakes
Sunshine Heart: Potential '10 To 100 Bagger' Re-Visited - Part I by Robert Honeywill
Advanced Micro Devices: An In-Depth Look At Steamroller And The Upcoming Kaveri APU by Justin Jaynes
Why Apple's Downside Is So Limited by Intelligent Speculator
Bank Of America: Why The 'Dead Money' Thesis Is Short Sighted by Josh Arnold
Why Warren Buffett Did Not Buy The Washington Post by Don Dion
Qualstar: A Beaten Down Company With 50% Upside Potential by Matthew Dow
Landec: An Attractive Company With 83% Upside by Austin Mading
Wal-Mart - Less Than Great Results Have Undervalued This Retail Giant by Mark Kowalski
AMR Corp Shows How Useful A Chapter-11 Reorganization Can Be by The Investment Doctor
The iPhone 5S's Graphics Are Insane by Tom Shaughnessy
AMC Networks Is Becoming Power To Reckon With by Gary Bourgeault
Amazon: Profitless Prosperity by Fred Wilson
Sell Netflix And Buy Starz by BuySellShort
Mondelēz International - Packed Full Of Opportunities by Bidness Etc
Killing Cancer Stem Cells: The Final Battle? by Peter Geschek
Veeco: Downgrade Presents A Great Buying Opportunity by Marshall Hargrave
Kaiser Aluminum & The Aerospace Inventory Overhang by Pendulum
Body Central: Multi-Bagger In The Making? by Brian Grosso
Europe Embraces Groundbreaking Cancer Therapy by Sharon di Stefano
USA Trucks Goes On The Offense With Knight Transportation by MTF Investing
Should You Add This Small Refiner, Backed By Israel's Energy Giant, To Your Portfolio? by Sarfaraz A. Khan
Short Ideas
Spark Networks Falls Behind In The Online Dating Revolution by Equity Options Guru
Chipotle: Investors Need To Pay A Gigantic Growth Premium, Avoid At All Costs by Achilles Research
Amazon: Bigger, But Certainly Not Better by Bill Maurer
Microsoft: Now We Flip Flop by Bill Maurer
The Real Reason ARMH Plummeted After Earnings by Volcano Steve
MicroStrategy: A Strategy To Sell by Marshall Hargrave
Quick Picks & Lists
Why These Dry Shipping Stocks Are Dropping Like Flies by The Specialist
Beer Brewing Excellence: The 6 Top Performing Companies by Lisa Tamayo-Kennedy
Amazon: Another Step Towards A Multi-Billion Dollar Industry by Vivek Gupta
3M: Already Highly Valued, General Electric And Siemens Might Be Better Deals by Achilles Research
Don't Go Apple Picking Yet by Julius Ferraro
Why Chesapeake Energy Isn't A Takeover Target by Achilles Research
What To Look For In The Ad-Tech Industry by John Mylant
Cramer's Picks
Cramer's Lightning Round - It Is Never Too Late To Get Into Icahn Enterprises (10/25/13) by SA Editor Miriam Metzinger
Cramer's Mad Money - 11 Earnings To Watch In The Week Ahead (10/25/13) by SA Editor Miriam Metzinger
Insider Ownership
Insiders Are Selling Microsemi by Markus Aarnio
IPO Analysis
Essent Group IPO Is A Go by Don Dion
Why are you receiving this? You subscribed to Investing Ideas at Seeking Alpha.
Unsubscribe from this email or manage all your Seeking Alpha email choices here.
To ensure you receive these emails in the future, please add account@seekingalpha.com to your address book, contacts or list of safe senders.
Sent by Seeking Alpha, 345 7th Ave. Suite 1400 New York, NY 10001
No hay comentarios:
Publicar un comentario